Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Bolt Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −4 vs. Q2 2024
- Shares held
- 18.8M
- −3.58M (−16.0%) vs. Q2 2024
- Total value
- $12.2M
- −$4.60M (−27.4%) vs. Q2 2024
- New holders
- 2
- 8 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Salem Investment Counselors Inc | 40 | $26 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 139 | $90 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 184 | $119 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 914 | $592 | 0.00% | +74+8.8% | Added |
| Bank of America Corp | 6,000 | $3.89K | 0.00% | +5,372+855.4% | Added |
| Advisor Group Holdings, Inc. | 17,355 | $11.3K | 0.00% | +2,355+15.7% | Added |
| Assenagon Asset Management S.A. | 20,785 | $13.5K | 0.00% | −13,703−39.7% | Reduced |
| Morgan Stanley | 23,449 | $15.2K | 0.00% | −10,238−30.4% | Reduced |
| Two Sigma Securities, LLC | 25,509 | $16.5K | 0.00% | −28,377−52.7% | Reduced |
| Jane Street Group, LLC | 28,102 | $18.2K | 0.00% | −13,426−32.3% | Reduced |
| UBS Group AG | 35,297 | $22.9K | 0.00% | −13,528−27.7% | Reduced |
| Mariner, LLC | 40,535 | $26.3K | 0.00% | +40,535 | New |
| Northern Trust Corp | 40,895 | $26.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 47,437 | $30.7K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 59,200 | $38.4K | 0.00% | +4,800+8.8% | Added |
| Bridgeway Capital Management, LLC | 60,200 | $39.0K | 0.00% | −25,000−29.3% | Reduced |
| FMR LLC | 115,386 | $74.8K | 0.00% | +28,773+33.2% | Added |
| Susquehanna International Group, LLP | 147,926 | $95.9K | 0.00% | +125,516+560.1% | Added |
| ADAR1 Capital Management, LLC | 244,966 | $158.7K | 0.03% | +58,967+31.7% | Added |
| BlackRock, Inc. | 269,608 | $174.7K | 0.00% | +269,608 | New |
| Renaissance Technologies LLC | 294,039 | $190.5K | 0.00% | +17,300+6.3% | Added |
| Geode Capital Management, LLC | 352,426 | $228.4K | 0.00% | −18,364−5.0% | Reduced |
| Newtyn Management, LLC | 468,910 | $303.9K | 0.05% | −894,324−65.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 500,000 | $324.0K | 0.00% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $466.3K | 0.04% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,049,153 | $679.9K | 0.13% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,067,405 | $691.7K | 0.00% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $756.2K | 0.65% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1.23M | 0.73% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 2,754,437 | $1.78M | 0.15% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,521,291 | $2.28M | 0.19% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,812,773 | $2.47M | 0.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,367,511−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −630,507−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −113,797−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −358−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |